Intellipharmaceutics International - Delisted OTC Stock
Intellipharmaceutics International is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Intellipharmaceutics was actively traded.
Intellipharmaceutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Intellipharmaceutics market risk premium is the additional return an investor will receive from holding Intellipharmaceutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Intellipharmaceutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Intellipharmaceutics' alpha and beta are two of the key measurements used to evaluate Intellipharmaceutics' performance over the market, the standard measures of volatility play an important role as well.
| Risk Adjusted Performance | 0.014 | |||
| Jensen Alpha | 0.0675 | |||
| Total Risk Alpha | (0.98) | |||
| Sortino Ratio | 7.0E-4 |
Intellipharmaceutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intellipharmaceutics otc stock to make a market-neutral strategy. Peer analysis of Intellipharmaceutics could also be used in its relative valuation, which is a method of valuing Intellipharmaceutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Intellipharmaceutics Corporate Management
Elected by the shareholders, the Intellipharmaceutics' board of directors comprises two types of representatives: Intellipharmaceutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intellipharmaceutics. The board's role is to monitor Intellipharmaceutics' management team and ensure that shareholders' interests are well served. Intellipharmaceutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intellipharmaceutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amina Odidi | COO and President | Profile | |
| Isa MBA | Chairman, CoFounder | Profile | |
| Patrick Yat | VicePres Services | Profile | |
| Fazayill Shaideen | Controller | Profile |
Still Interested in Intellipharmaceutics International?
Investing in delisted otcs can be risky, as the otc stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Intellipharmaceutics OTC Stock
If you are still planning to invest in Intellipharmaceutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intellipharmaceutics' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |